Using a web-based system , we randomly assigned patients who met full inclusion criteria after screening ( @:@ ; random permuted block length four ) to celgosivir ( initial @ mg loading dose within @ h of randomisation , followed by @ mg every @ h for a total of nine doses ) or matched placebo .